Baba T, Mandai M, Nishi H, Nishii O, Kitawaki J, Sawada M, Isaka K, Fujii T.Early feasibility surveillance of gynecologic robotic-assisted surgeries in Japan. J Obstet Gynaecol Res. 2019 ; 45(4) : 787-793
Shoji T, Takatori E, Kagabu M, Futagami Y, Yokoyama Y, Tokunaga H, Yaegashi N, Ohta T, Watanabe T, Sugiyama T. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer(TGCU 104 study) Eur J Gynaecol Oncol 2020 (In press)
Onoue H, Baba T, Koiwa K, Kon M, Ikeda M, Kumagai J. Department of Obstetrics and Gynecology, School of Clinical relevance of endometrial polyps diagnosed by hysteroscopy in 613 infertile women: a retrospective, single-center, cohort study Obstet Gynecol Int J. 2020 ; 11(3) : 137-141
Onoue H, Baba T, Koiwa K, Kon M, Tsuchiya S, Satoh C. Treatment outcomes of intrauterine insemination and pregnancy prognosis factors: a retrospective single-center cohort study 2020 ; 4(3) : 78‒81
Sasaki Y, Baba T, Oyama R, Fukumoto K, Haba G, Sasaki M. Re-evaluation of the Edinburgh Postnatal Depression Scale as screening for post-partum depression in Iwate Prefecture, Japan. J Obstet Gynaecol Res. 2019 Sep ; 45(9) : 1876-1883.
Natori N, Haba G, Kawamura H, Terata M, Isurugi C, Sasaki Y, Hatayama S, Oyama R, Baba T. Evaluation of Normal Fetal Heart Function by Novel Obstetrics Ultrasound. Clinics Mother Child Health, 2020 17(2)No : 344. (in press)
Natori N, Oyama R , Baba T, Isurugi C, Chida H, Haba G , Sasaki Y, Kanasugi T, Itamochi H ,Kikuchi A .Velocity vector imaging for evaluation of fetal vertical function throughout gestation .HRP. 2019. 1-8.
Takeuchi S, Shoji T, Kagabu M, Honda T, Nagasawa T, Nitta Y, Sugiyama T, Yoshimura S, Nakamura Y, Anti-cancer Immunotherapy Epitope-peptides Vaccination in Patients with Refractory/Persistent Disease of Cervical Cancer and Ovarian Cancer (Phase 1 Studies). Cancer Research J 2019, 7(3), 106-116.
Fujiwara H, Ushijima K, Nagao S, Takei Y, Shimada M, Takano M, Yoshino K, Kawano Y, Hirashima Y, Nagase S, Nishio S, Nishikawa T, Ito K, Shoji T, Kimura E, Takano T, Sugiyama T, Kigawa J, Fujiwara K, Suzuki M. A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study). Int J Clin Oncol. 2019, 24 : 1284-1291.
Kawaguchi R, Matsumoto K, Akira S, Ishitani K, Iwasaku K, Ueda Y, Okagaki R, Okano H, Oki T, Koga K, Kido M, Kurabayashi T, Kuribayashi Y, Sato Y, Shiina K, Takai Y, Tanimura S, Chaki O, Terauchi M, Todo Y, Noguchi Y, Nose-Ogura S, Baba T, Hirasawa A, Fujii T, Fujii T, Maruyama T, Miyagi E, Yanagida K, Yoshino O, Iwashita M, Maeda T, Minegishi T, Kobayashi H. Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition. J Obstet Gynaecol Res. 2019 ; 45(4) : 766-786. 30675969.
Ikeda A, Kondoh E, Chigusa Y, Mogami H, Kameyama Nakao K, Kido A, Horie A, Baba T, Hamanishi J, Mandai M. Novel subtype of atonic postpartum hemorrhage: dynamic computed tomography evaluation of bleeding characteristics and the uterine cavity. J Matern Fetal Neonatal Med. 2019 31 : 1-7.
Kawasaki K, Kondoh E, Chigusa Y, Kawamura Y, Mogami H, Takeda S, Horie A, Baba T, Matsumura N, Mandai M, Konishi I. Metabolomic Profiles of Placenta in Preeclampsia. Hypertension. 2019 ; 73(3) : 671-679.
Mulati K, Hamanishi J, Matsumura N, Chamoto K, Mise N, Abiko K, Baba T, Yamaguchi K, Horikawa N, Murakami R, Taki M, Budiman K, Zeng X, Hosoe Y, Azuma M, Konishi I, Mandai M. VISTA expressed in tumour cells regulates T cell function. Br J Cancer. 2019 ; 120(1) : 115-127.
Nakamura A, Yamaguchi K, Minamiguchi S, Murakami R, Abiko K, Hamanishi J, Kondoh E, Baba T, Mandai M, Matsumura N. Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification. Med Mol Morphol. 2019 ; 52(1) : 52-59.
Zeng X, Baba T, Hamanishi J, Matsumura N, Kharma B, Mise Y, Abiko K, Yamaguchi K, Horikawa N, Hunstman DG, Mulati K, Kitamura S, Taki M, Murakami R, Hosoe Y, Mandai M. Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma. Int J Cancer. 2019 Sep 15 ; 145(6) : 1635-1647.
Watanabe T, Soeda S, Nishiyama H, Kiko Y, Tokunaga H, Shigeta S, Yaegashi N, Yamada H, Ohta T, Nagase S, Shoji T, Kagabu M, Baba T, Shimizu D, Sato N, Terada Y, Futagami M, Yokoyama Y, Fujimori K. Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer. Mol Clin Oncol. 2020 ; 12(1) : 44-50.
Kuwahara R, Kido A, Yajima R, Nishio N, Nakao K, Kurata Y, Tanaka S, Minamiguchi S, Baba T, Mandai M, Togashi K. Microcystic, Elongated and Fragmented Pattern Invasion Can Adversely Influence Preoperative Staging for Low-grade Endometrial Carcinoma. Magn Reson Med Sci. 2020 Feb 19.
Horikawa N, Abiko K, Matsumura N, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Taki M, Ukita M, Hosoe Y, Koshiyama M, Konishi I, Mandai M. Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment. Br J Cancer. 2020 Mar ; 122(6) : 778-788.
So M, Miyamoto T, Murakami R, Abiko K, Hamanishi J, Baba T, Mandai M. The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients. J Gynecol Oncol. 2019 Nov ; 30(6) : e100.
Yamanoi K, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Murakami R, Taki M, Hosoe Y, Murphy SK, Konishi I, Mandai M, Matsumura N. Acquisition of a side population fraction augments malignant phenotype in ovarian cancer. Sci Rep. 2019 ; 9(1) : 14215.
英文症例報告
Shoji T, Takeshita R, Saito T, Aida T, Sasou S, Baba T. A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy. J Ovarian Res. 2020 Mar 21 ; 13(1) : 33.
Kanasugi T, Sasaki Y, Haba G, Oyama R, Kikuchi A. Successive monochorionic twin pregnancies after assisted reproductive technology complicated by repeated twin reversed arterial perfusion sequence. Congenit Anom . 2019 Jul 10. 1-2.
Fukagawa Y, Itamochi H, Sato C, Tomabechi H, Nagasawa H, Kagabu M, Shoji T, Sugai T, Baba T. Primary y ovarian serous psammocarcinoma-a case report with mini literature review. Obstet Gynecol Int J.2020 ; 11(3) : 192‒195.
Osakabe M, Sato C, Suzuki M, Sugimoto R, Fujita Y, Uesugi N, Ishida K, Itamochi H, Baba T, Sugai T. Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report. Diagn Pathol. 2019 1 ; 14(1) : 27.
Hamada K, Baba T, Takaori A, Murakami R, Horie A, Abiko K, Minamiguchi S, Mandai M. Primary signet ring cell carcinoma of uterine cervix and related disease: two case reports and a review. Int Cancer Conf J. 2019 May 17 ; 8(4): 157-163.
英文総説
Shoji T, Eto H, Sato T, Soma R, Fukagawa D, Tomabechi H, Takatori E, Nagasawa T, Sato S, Kagabu M, Baba T.A New Therapeutic Strategy for Recurrent Ovarian Cancer-Bevacizumab beyond Progressive Disease. Healthcare. 2019 19 ; 7(3).
Kagabu M, Nagasawa T, Fukagawa D, Tomabechi H, Sato S, Shoji T, Baba T.Immunotherapy for Uterine Cervical Cancer. Healthcare (Basel). 2019 Sep 17 ; 7(3). pii : E108.
Kagabu M, Nagasawa T, Sato C, Fukagawa Y, Kawamura H, Tomabechi H, Takemoto S,Shoji T, Baba T. Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions. Int J Mol Sci. 2020 Mar 27 ; 21(7). pii : E2335.
Shoji T, Nagasawa T, Kagabu M, Baba T, Futagami M, Tokunaga H, Yaegashi N, Ohta T, Watanabe T, Yokoyama Y. A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study). the 6th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2019) Oct. 2019, Incheon, Korea
Sato S. Outcome of patients with uterine cervical cancer undergoing radical hysterectomy using the 2018 FIGO staging. the 6th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2019) Oct. 2019, Incheon, Korea
Soma R, Shoji T, Nagasawa T, Sato C, Fukagawa Y, Kawamura H, Tomabechi H, Kagabu M, Baba T. A case of primary signet ring cell carcinoma of the uterine cervix treated with CPT-11/S-1 therapy. the 6th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2019) Oct. 2019, Incheon, Korea
Baba T. MIGS committee’s plan: Prevail MIGS more! Proceed MIGS safer! Prospect MIGS’ Future! AOFOG Acton Plan Meeting. Jun.2020. Luang Prabang, Laos
国内学会発表 全国
招聘講演等
馬場 長.そもそもLACC trialは悪かったのか?~何を prevent すればよいのか~「特別企画:LACC trial 何が悪かったのか?―俺の preventive technique for cancer cell spillagee ―」第41回日本産婦人科手術学会 2019年2月.東京